Search

everythinglearnresearchcommunity

for

Search:↓

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Latanoprost may cause scalp inflammation and delayed healing.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Kerion cases had longer disease duration but responded well to antifungal treatments.

A 21-year-old with lichen planopilaris was successfully treated, stopping disease progression and preventing crusts.

The study concluded that short vellus hair and yellow dots were the most common signs of alopecia areata, indicating disease activity and remission.

Psoriasis is a common, genetically influenced skin disease worsened by stress and lifestyle, but targeted treatments are promising.

Botulinum toxin A may be an effective alternative treatment for the scalp disorder folliculitis decalvans.

Eyebrow reconstruction using hair follicle grafts was successful in a man with a benign hereditary disorder affecting his eyebrows.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Acneiform follicular mucinosis can be controlled with systemic corticosteroids.

A skin condition called pyodermatitis vegetans was found in a patient with multiple myeloma for the first time.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

The link between pemphigus and the patient's scarring hair loss is still unclear.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Japanese cases of fibrosing alopecia show a unique age and hair loss pattern, possibly due to racial differences.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Lupus can cause hair loss and nail changes, with treatments available for both.